Shares of Gilead Sciences Inc. GILD advanced 3.57% to $106.16 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.09% to 5,963.60 ...

Gilead Sciences, Inc. (NASDAQ:GILD)  plans to present over 20 research abstracts—spanning both Gilead and its cell therapy unit Kite—at two major medical conferences: the 2025 ASCO Annual Meeting (May ...

Detailed Analysis Into the Regulatory Landscape, Patent Landscape, Key Trends, Clinical Trails, Pricing Analysis, Market Dynamics and MoreDublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "Adult T-Cell ...

The band A.D.D. performs at the Pearson Scholarship Hall Rock-A-Thon on Saturday, May 3, 2025, on the KU campus.

A subsidiary of Gilead Sciences, Kite Pharma is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered ...

Pharmaceutical firm Gilead has admitted paying hundreds of thousands of dollars in illegal kickbacks to US doctors between January 2011 and November 2017, as inducements for prescribing the company’s ...

Yellow Kite has unveiled a new logo and strapline – “books for life” – to mark the lifestyle and wellbeing imprint’s 10th year of publishing. Founded in 2014, the imprint has published ...

When it comes to moms, there’s no one better than yours, which is why it's extra important to recognize her — or any other special woman in your life — this Mother's Day. After all, moms ...

Gilead Sciences to Pay $202 Million in US Settlement Over HIV Drug Kickbacks By Jonathan Stempel NEW YORK (Reuters) -Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit ...

Often we make mistakes under duress.” 'The Handmaid's Tale' Star Yvonne Strahovski on Serena's Explosive, Pro-Gilead Train Speech: 'She Really Can't Read the Room' In a surprising, or maybe not ...

After a somewhat slow start, the sixth and final season of The Handmaid's Tale has kicked up a notch ahead of Mayday's strike on Gilead, which was imminent, but has since suffered a colossal ...